個體化精神病學市場：按類型、治療領域和地區

Personalized Psychiatry Market, By Type, By Therapeutic Areas, By Region

出版日期: 2023年12月21日 | 出版商:

Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

個體化精神病學市場規模預計將從 2023 年的 41 億美元增加到 2030 年的 86.8 億美元，預測期內複合年成長率為 11.3%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	41億美元
實績資料	2018-2021	預測期	2023-2030
預測期複合年成長率	11.30%	2030年市場規模預測	86.8億美元

圖 1. 2023 年個體化精神醫學全球市場佔有率（按地區分類）

個體化精神病學是精神健康保健領域的一個新領域，旨在改變精神疾病的診斷和治療方式。傳統上，精神病學依賴一刀切的方法，根據廣泛的診斷標準為患者開藥和治療方法。個體化精神病學利用每個患者特有的遺傳、生物和臨床資料來創建針對其心理健康的治療方法和療法。個體化精神病學旨在用更有針對性和客製化的策略取代一刀切的策略。使用的一些關鍵技術包括穿戴式生物感測器、電腦化治療程序、定量腦電圖、藥物基因組測試和分子診斷。人們對心理健康問題認知的提高、神經生物學和基因組學的進步以及對更好的心理健康診斷和治療結果的需求是推動市場的關鍵因素。

市場動態：

由於數位健康技術的快速進步、基因組學、穿戴式裝置和行動應用程式的創新等幾個關鍵因素，個體化精神病學市場預計將在未來幾年顯著成長。此外，心理健康評估和治療領域的人工智慧也有望在預測期內推動市場成長。這些技術可以實現即時資料收集，使臨床醫生能夠遠端監控患者並做出資訊的護理決策。

然而，個體化精神病學市場也面臨一些挑戰。阻礙因素因素之一是實施個體化方法的高成本。開發和實施先進技術可能成本高昂，而且這些服務的報銷選項可能有限。此外，在精神健康保健中使用資料和數位資料還存在監管和倫理方面的考慮，這可能會延遲個體化方法的採用。

本研究的主要特點

本報告對全球個體化心理健康護理市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030）的市場規模和復合年成長率。
它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球個體化精神病學市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
全球個體化精神病學市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球個體化精神病學市場的各種策略矩陣，將有助於相關人員做出決策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 4.10 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	11.30%	2030 Value Projection:	US$ 8.68 Bn

Personalized psychiatry is an emerging field within the realm of mental healthcare that aims to revolutionize the way mental illnesses are diagnosed and treated. Traditionally, psychiatry has relied on a one-size-fits-all approach, where patients are prescribed medications or therapies based on broad diagnostic criteria. Using individual patient-specific genetic, biological, and clinical data, personalized psychiatry creates specialized mental health treatments and therapies. It seeks to replace the one-size-fits-all strategy with a more focused, customized one. Among the important technologies utilized are wearable biosensors, computerized therapy programs, quantitative EEG, pharmacogenomic testing, and molecular diagnostics. Growing public awareness of mental health issues, developments in neurobiology and genomics, and the need for better mental health diagnosis and treatment outcomes are the primary factors propelling the market.

Market Dynamics:

The personalized psychiatry market is expected to witness significant growth in the coming years, driven by several key factors such as rapid advancement of digital health technologies, innovations in genomics, wearables, and mobile apps. In addition, artificial intelligence in the field of mental health assessment and treatment is also expected to drive market growth over the forecast period. These technologies enable the collection of real-time data, allowing clinicians to monitor patients remotely and make informed decisions about their care.

However, the personalized psychiatry market also faces some challenges. One of the main restraints is the high cost associated with implementing personalized approaches. Developing and deploying advanced technologies can be expensive, and there may be limited reimbursement options for these services. Furthermore, there are regulatory and ethical considerations surrounding the use of genetic and digital data in mental healthcare, which may slow down the adoption of personalized approaches.

Key features of the study:

This report provides in-depth analysis of the global personalized psychiatry market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global personalized psychiatry market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GreyBird Ventures, Sunovion Pharmaceuticals Inc., HMNC Holding GmbH, Arcara Personalized Psychiatry, Starling Minds, Karuna Therapeutics, CBT Plus, AltheaDx, Inc., WayForward, BrightQuest, Peak Mental Wellness
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global personalized psychiatry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized psychiatry market

Detailed Segmentation:

By Type:
- Products
- Diagnostics
- Therapeutics
- Services
- Software
By Therapeutic Areas:
- Depression
- Anxiety
- Bipolar Disorder
- Schizophrenia
- Addiction
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Top companies in Personalized Psychiatry Market:
- GreyBird Ventures
- Sunovion Pharmaceuticals Inc.
- HMNC Holding GmbH
- Arcara Personalized Psychiatry
- Starling Minds
- Karuna Therapeutics
- CBT Plus
- AltheaDx, Inc.
- WayForward
- BrightQuest
- Peak Mental Wellness

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Personalized Psychiatry, By Type
- Market Personalized Psychiatry, By Therapeutic Areas
- Market Personalized Psychiatry, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing need for improved diagnosis and treatment outcomes in mental healthcare
- Rising prevalence of mental disorders
- Growing adoption of precision medicine model in healthcare
Restraints
Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Personalized Psychiatry Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Personalized Psychiatry Market , By Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Diagnostics
Therapeutics
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Personalized Psychiatry Market , By Therapeutic Areas, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Anxiety
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Bipolar Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Schizophrenia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Personalized Psychiatry Market , By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

GreyBird Ventures
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sunovion Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
HBNC Holding GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Arcara Personalized Psychiatry
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Starling Minds
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Karuna Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CBT Plus
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AltheaDx, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WayForward
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BrightQuest
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Peak Mental Wellness
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views